)
)
Dirk Paul
Dr Dirk Paul leads the Cardiovascular, Renal and Metabolic (CVRM) Therapeutic Area at the Centre for Genomics Research at AstraZeneca. As part of AstraZeneca's Integrated Genomics Initiative, Dr Paul is responsible for identifying new therapeutic targets, uncovering biological mechanisms that can be exploited for medicine development, and driving precision medicine strategies using genomics and data science approaches.
Before joining AstraZeneca, he was a Group Leader at the Cardiovascular Epidemiology Unit at the University of Cambridge. He trained in human genomics and functional genomics at the Wellcome Sanger Institute and University College London. A strong advocate for academia-industry collaborations, Dr Paul has published >85 articles and received a 2019 Sanofi Innovation Award.
Sessions
-
Advancing Beyond The Genome: AstraZeneca’s Approach to Delivering Tailored Treatments for Chronic Diseases28-Jan-2026Multi-Omics Integration Stage